1. Sun, G G, Zhang, J, Hu, W N. 2013. CCNG2 expression is downregulated in colorectal carcinoma and its clinical significance. In Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 35, 3339-46. doi:10.1007/s13277-013-1440-5. https://pubmed.ncbi.nlm.nih.gov/24307622/
2. Zhang, Danfeng, Wang, Chunhui, Li, Zhenxing, Hou, Lijun, Wang, Junyu. 2018. CCNG2 Overexpression Mediated by AKT Inhibits Tumor Cell Proliferation in Human Astrocytoma Cells. In Frontiers in neurology, 9, 255. doi:10.3389/fneur.2018.00255. https://pubmed.ncbi.nlm.nih.gov/29720957/
3. Qin, W-J, Wang, W-P, Wang, X-B, Zhang, X-T, Du, J-D. . MiR-1290 targets CCNG2 to promote the metastasis of oral squamous cell carcinoma. In European review for medical and pharmacological sciences, 23, 10332-10342. doi:10.26355/eurrev_201912_19671. https://pubmed.ncbi.nlm.nih.gov/31841213/
4. Li, Wei-Juan, Liu, Ge-Ling, Yu, Fang, Xiao, Hong-Zhen, Shi, Yan-Ping. . CCNG2 suppressor biological effects on thyroid cancer cell through promotion of CDK2 degradation. In Asian Pacific journal of cancer prevention : APJCP, 14, 6165-71. doi:. https://pubmed.ncbi.nlm.nih.gov/24289643/
5. Sun, G G, Hu, W N, Cui, D W, Zhang, J. 2013. Decreased expression of CCNG2 is significantly linked to the malignant transformation of gastric carcinoma. In Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 35, 2631-9. doi:10.1007/s13277-013-1346-2. https://pubmed.ncbi.nlm.nih.gov/24248541/
6. Chen, Lingling, Tang, Jie, Chang, Yunli, Ji, Jieru, Chen, Guoyu. 2024. SMURF1 leads to the β-catenin signaling-mediated progression of esophageal squamous carcinoma by losing PATZ1-induced CCNG2 transcription. In Biochemical pharmacology, 232, 116688. doi:10.1016/j.bcp.2024.116688. https://pubmed.ncbi.nlm.nih.gov/39617210/
智鼠故事 
